Press-release for stocks for snynf

approved symbols : Snynf

save search

First Approval for Rare Pediatric Cancer; New OTC Opioid Overdose Option
Published: 2024-04-24 (Crawled : 16:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -0.27% | O: 0.8% H: 0.0% C: -1.05%
PRGO | $31.23 2.43% 0.0% 960K

Health Technology

| 2.43% | O: -0.03% H: 2.66% C: 2.46%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -1.02% | O: -1.02% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M

Health Technology

| -0.65% | O: -0.82% H: 0.37% C: 0.17%
XOMA | $25.11 -3.76% -3.9% 8.2K

Health Technology

| -1.72% | O: 0.19% H: 0.0% C: -1.91%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| 0.82% | O: 0.82% H: 0.0% C: 0.0%
rare first opioid approval for

FDA Rejects Abeona’s Gene Therapy, Approves ImmunityBio’s Bladder Cancer Treatment
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K

Health Technology

| 3.89% | O: 0.13% H: 1.89% C: 1.3%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -0.13% | O: 0.89% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M

Health Technology

| -0.17% | O: 0.56% H: 0.41% C: -0.07%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| 2.53% | O: 1.7% H: 0.0% C: 0.0%
fda bladder cancer treatment

Busy Weekend Sees Tumor-Agnostic Win for Enhertu, Another Rejection for Supernus
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

Health Technology

| 1.41% | O: 2.24% H: 0.0% C: -0.8%
PRGO | $31.23 2.43% 0.0% 960K

Health Technology

| -0.54% | O: 0.96% H: 1.17% C: 0.16%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -2.88% | O: -0.48% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M

Health Technology

| -3.88% | O: 0.09% H: 0.16% C: -0.7%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| 1.11% | O: 0.84% H: 0.0% C: 0.0%
for

FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published: 2024-04-03 (Crawled : 13:30) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K

Health Technology

| -0.29% | O: -0.29% H: 1.34% C: -0.64%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -6.08% | O: 0.02% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M

Health Technology

| -4.58% | O: 0.11% H: 0.37% C: -0.77%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -0.53% | O: 0.69% H: 0.0% C: 0.0%
fda drug schizophrenia

AstraZeneca Kicks Off April With New PNH Approval
Published: 2024-04-02 (Crawled : 13:30) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K

Health Technology

| -2.74% | O: -1.09% H: 0.13% C: -1.39%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -6.11% | O: -0.77% H: 0.8% C: 0.74%
ABT | News | $106.89 -0.65% -0.22% 5.1M

Health Technology

| -4.64% | O: -0.18% H: 0.47% C: 0.12%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -2.71% | O: -1.14% H: 0.02% C: -1.06%
approval astrazeneca

FDA Approves Treatments for Anemia in Chronic Kidney Disease, Hepatitis
Published: 2024-03-29 (Crawled : 19:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| Email alert Add to watchlist
ABT | News | $106.89 -0.65% -0.22% 5.1M

Health Technology

| Email alert Add to watchlist
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| Email alert Add to watchlist
PRGO | $31.23 2.43% 0.0% 960K

Health Technology

| Email alert Add to watchlist
SNYNF | News | $94.25 -2.18% 480

Health Technology

| Email alert Add to watchlist
fda hepatitis kidney anemia

FDA Approves New Treatments for Two Rare Diseases
Published: 2024-03-27 (Crawled : 13:30) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -5.96% | O: -0.26% H: 0.0% C: 0.0%
PRGO | $31.23 2.43% 0.0% 960K

Health Technology

| 1.4% | O: 0.84% H: 1.48% C: 1.29%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -4.81% | O: 0.3% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M

Health Technology

| -3.21% | O: 1.48% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -3.57% | O: 1.06% H: 0.0% C: 0.0%
fda rare

COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024: Glo...
Published: 2024-03-27 (Crawled : 13:30) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -5.96% | O: -0.26% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -3.57% | O: 1.06% H: 0.0% C: 0.0%
copd potential market

COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024: GlobalData
Published: 2024-03-27 (Crawled : 12:30) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -5.96% | O: -0.26% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -3.57% | O: 1.06% H: 0.0% C: 0.0%
copd potential market

Regeneron Hit With Two CRLs, J&J’s PAH Treatment Approved
Published: 2024-03-25 (Crawled : 15:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

Health Technology

| 0.3% | O: -100.0% H: NaN% C: Infinity%
PRGO | $31.23 2.43% 0.0% 960K

Health Technology

| -0.29% | O: 0.35% H: 0.35% C: -1.34%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -4.77% | O: 0.04% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M

Health Technology

| -3.33% | O: -0.07% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -1.3% | O: 0.42% H: 0.0% C: 0.0%
approved treatment

Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nod for DMD, Hypertension
Published: 2024-03-22 (Crawled : 14:30) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -1.29% | O: -1.58% H: 0.0% C: 0.0%
PRGO | $31.23 2.43% 0.0% 960K

Health Technology

| -1.11% | O: 0.35% H: 0.99% C: -1.17%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -4.75% | O: 0.02% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M

Health Technology

| -4.56% | O: -0.43% H: 0.41% C: -0.85%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -0.03% | O: 1.47% H: 0.23% C: -0.19%
fda hypertension

FDA Approves Takeda’s Iclusig for Type of Leukemia, Idorsia’s Hypertension Drug
Published: 2024-03-21 (Crawled : 13:30) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -0.92% | O: 0.14% H: 0.24% C: 0.24%
PRGO | $31.23 2.43% 0.0% 960K

Health Technology

| -0.22% | O: 0.0% H: 1.6% C: 0.89%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -4.78% | O: -0.03% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M

Health Technology

| -5.1% | O: -0.56% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| 0.26% | O: 0.3% H: 0.0% C: 0.0%
fda drug iclusig hypertension

FDA Approves First Gene Therapy for Rare Pediatric Disease
Published: 2024-03-18 (Crawled : 23:00) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K

Health Technology

| 2.83% | O: 0.33% H: 0.13% C: -1.51%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -6.39% | O: 0.2% H: 0.08% C: -1.14%
ABT | News | $106.89 -0.65% -0.22% 5.1M

Health Technology

| -5.75% | O: 1.71% H: 0.36% C: -2.52%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -2.01% | O: -0.81% H: 0.0% C: 0.0%
fda rare first disease therapy

Madrigal’s Rezdiffra, BMS’s Breyanzi Lead Week of Landmark FDA Approvals
Published: 2024-03-15 (Crawled : 15:00) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K

Health Technology

| 1.17% | O: -0.62% H: 0.59% C: -1.01%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -7.87% | O: -1.58% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M

Health Technology

| -10.96% | O: -5.53% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -2.03% | O: -0.02% H: 0.0% C: 0.0%
fda breyanzi week

FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug ...
Published: 2024-03-11 (Crawled : 17:00) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K

Health Technology

| 3.24% | O: 0.0% H: 2.38% C: 1.12%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -6.79% | O: 0.43% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M

Health Technology

| -11.51% | O: 0.26% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -1.28% | O: 0.57% H: 0.0% C: 0.0%
fda drug wegovy approved

FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug Rejected
Published: 2024-03-11 (Crawled : 14:30) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K

Health Technology

| 3.24% | O: 0.0% H: 2.38% C: 1.12%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -6.79% | O: 0.43% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M

Health Technology

| -11.51% | O: 0.26% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -1.28% | O: 0.57% H: 0.0% C: 0.0%
fda drug wegovy approved

Praluent® (alirocumab) Injection Receives FDA Approval to Treat Children with Genetic Form of High Cholesterol
Published: 2024-03-11 (Crawled : 11:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -1.28% | O: 0.57% H: 0.0% C: 0.0%
REGN | News | $906.55 -0.09% -0.08% 370K

Health Technology

| -6.43% | O: 0.23% H: 0.9% C: -0.68%
praluent fda children genetic cholesterol approval treat injection

FDA Decisions: BeiGene Secures Record Fifth Oncology Approval for Brukinsa
Published: 2024-03-08 (Crawled : 18:00) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K

Health Technology